• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Anakinra
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart

    Interlukin-1 Receptor Inhibitor. Anakinra 150 mg/ml.
    PREFILL. SYR (sol.for inject.): 1, 28. 1 x dly,
    S.C. inject. in pts. > 18 yrs.
    treatment of the signs and symptoms of
    rheumatoid arthritis in combination with
    Methotrexate, in patients with an
    inadequate response to Methotrexate
    alone. adults, adolescents, children and
    infants aged 8 months and older with a
    body weight of 10 kg or above for the
    treatment of Cryopyrin-Associated
    Periodic Syndromes (CAPS), including:
    Neonatal-Onset Multisystem
    Inflammatory Disease (NOMID) /Chronic
    Infantile Neurological, Cutaneous,
    Articular Syndrome (CINCA)Muckle-Wells
    Syndrome (MWS). Familial Cold
    Autoinflammatory Syndrome (FCAS).
    C/I: Hypersensitivity to the active
    substance or to any of the excipients or
    to E. coli derived proteins. Kineret must
    not be used in patients with severe renal
    impairment (CLcr < 30 ml/minute)
    Kineret treatment must not be initiated
    in patients with neutropenia (ANC <1.5 x